Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A

J. H S Kabarowski, K. Zhu, L. Q. Le, O. N. Witte, Y. Xu

Research output: Contribution to journalArticle

250 Citations (Scopus)

Abstract

Although the biological actions of the cell membrane and serum lipid lysophosphatidylcholine (LPC) in atherosclerosis and systemic autoimmune disease are well recognized, LPC has not been linked to a specific cell-surface receptor. We show that LPC is a high-affinity ligand for G2A, a lymphocyte-expressed G protein-coupled receptor whose genetic ablation results in the development of autoimmunity. Activation of G2A by LPC increased intracellular calcium concentration, induced receptor internalization, activated ERK mitogen-activated protein kinase, and modified migratory responses of Jurkat T lymphocytes. This finding implicates a role for LPC-G2A interaction in the etiology of inflammatory autoimmune disease and atherosclerosis.

Original languageEnglish (US)
Pages (from-to)702-705
Number of pages4
JournalScience
Volume293
Issue number5530
StatePublished - Jul 27 2001

Fingerprint

Lysophosphatidylcholines
Ligands
Autoimmune Diseases
Atherosclerosis
Cell Surface Receptors
Membrane Lipids
G-Protein-Coupled Receptors
Mitogen-Activated Protein Kinases
Autoimmunity
G2A receptor
Lymphocytes
Calcium
T-Lymphocytes
Serum

ASJC Scopus subject areas

  • General

Cite this

Kabarowski, J. H. S., Zhu, K., Le, L. Q., Witte, O. N., & Xu, Y. (2001). Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science, 293(5530), 702-705.

Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. / Kabarowski, J. H S; Zhu, K.; Le, L. Q.; Witte, O. N.; Xu, Y.

In: Science, Vol. 293, No. 5530, 27.07.2001, p. 702-705.

Research output: Contribution to journalArticle

Kabarowski, JHS, Zhu, K, Le, LQ, Witte, ON & Xu, Y 2001, 'Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A', Science, vol. 293, no. 5530, pp. 702-705.
Kabarowski JHS, Zhu K, Le LQ, Witte ON, Xu Y. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science. 2001 Jul 27;293(5530):702-705.
Kabarowski, J. H S ; Zhu, K. ; Le, L. Q. ; Witte, O. N. ; Xu, Y. / Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. In: Science. 2001 ; Vol. 293, No. 5530. pp. 702-705.
@article{b9ff8135112844cca608bff8c797f4cf,
title = "Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A",
abstract = "Although the biological actions of the cell membrane and serum lipid lysophosphatidylcholine (LPC) in atherosclerosis and systemic autoimmune disease are well recognized, LPC has not been linked to a specific cell-surface receptor. We show that LPC is a high-affinity ligand for G2A, a lymphocyte-expressed G protein-coupled receptor whose genetic ablation results in the development of autoimmunity. Activation of G2A by LPC increased intracellular calcium concentration, induced receptor internalization, activated ERK mitogen-activated protein kinase, and modified migratory responses of Jurkat T lymphocytes. This finding implicates a role for LPC-G2A interaction in the etiology of inflammatory autoimmune disease and atherosclerosis.",
author = "Kabarowski, {J. H S} and K. Zhu and Le, {L. Q.} and Witte, {O. N.} and Y. Xu",
year = "2001",
month = "7",
day = "27",
language = "English (US)",
volume = "293",
pages = "702--705",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "5530",

}

TY - JOUR

T1 - Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A

AU - Kabarowski, J. H S

AU - Zhu, K.

AU - Le, L. Q.

AU - Witte, O. N.

AU - Xu, Y.

PY - 2001/7/27

Y1 - 2001/7/27

N2 - Although the biological actions of the cell membrane and serum lipid lysophosphatidylcholine (LPC) in atherosclerosis and systemic autoimmune disease are well recognized, LPC has not been linked to a specific cell-surface receptor. We show that LPC is a high-affinity ligand for G2A, a lymphocyte-expressed G protein-coupled receptor whose genetic ablation results in the development of autoimmunity. Activation of G2A by LPC increased intracellular calcium concentration, induced receptor internalization, activated ERK mitogen-activated protein kinase, and modified migratory responses of Jurkat T lymphocytes. This finding implicates a role for LPC-G2A interaction in the etiology of inflammatory autoimmune disease and atherosclerosis.

AB - Although the biological actions of the cell membrane and serum lipid lysophosphatidylcholine (LPC) in atherosclerosis and systemic autoimmune disease are well recognized, LPC has not been linked to a specific cell-surface receptor. We show that LPC is a high-affinity ligand for G2A, a lymphocyte-expressed G protein-coupled receptor whose genetic ablation results in the development of autoimmunity. Activation of G2A by LPC increased intracellular calcium concentration, induced receptor internalization, activated ERK mitogen-activated protein kinase, and modified migratory responses of Jurkat T lymphocytes. This finding implicates a role for LPC-G2A interaction in the etiology of inflammatory autoimmune disease and atherosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=0035958728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035958728&partnerID=8YFLogxK

M3 - Article

C2 - 11474113

AN - SCOPUS:0035958728

VL - 293

SP - 702

EP - 705

JO - Science

JF - Science

SN - 0036-8075

IS - 5530

ER -